Twice-Yearly Injection Shows Promise For High Blood Pressure Treatment In Global Trial
A global phase 2 trial found twice-yearly zilebesiran injections significantly reduce systolic blood pressure in high blood pressure patients.
Read MoreALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A global phase 2 trial found twice-yearly zilebesiran injections significantly reduce systolic blood pressure in high blood pressure patients.
Read MoreUS measles cases exceed 1,714 as of April 9, 2026, with 17 outbreaks across 33 states, including a major surge in Utah, CDC reports.
Read MoreNew unit sales sit at half their 2006 peak. The median buyer is 50. Harley-Davidson fell to third place in 2025. Tariffs are pushing prices up 35%. And the industry’s DEI crisis has made motorcycling
Read MoreResearchers identified how aggressive breast cancer suppresses immune response by altering bone marrow and inhibiting T cell activation.
Read MoreThe Suwalki Gap — a 65-kilometer corridor between Poland and Lithuania — is NATO’s most vulnerable chokepoint, and Russia is already waging a hybrid war to exploit it through GPS jamming, cable sabotage, weaponized migration, and military intimidation.
Read MoreUS motorcycle sales fell 7.6% in 2025. The median buyer is 50. And the editors gatekeeping moto media are amplifying the political identity that makes the sport radioactive to younger, more diverse potential riders.
Read MoreMetformin raises exercise-related molecule Lac-Phe in prostate cancer patients, mimicking exercise benefits across all disease stages.
Read MoreThe SEO tools market is undergoing a fundamental shift. For over a decade, agencies and in-house teams have paid $99
Read MoreThe CDC delayed a report showing the 2024–2025 COVID-19 vaccine reduced ER visits by 33% and hospitalizations by up to 46% in U.S. adults.
Read MoreA University of Chicago study found zeaxanthin enhances CD8+ T cell function and improves cancer immunotherapy efficacy in preclinical models.
Read More